Trauma is the leading cause of death in the U.S. between the ages of 1 and 46, accounting for 41 million ER visits each year. Trauma patients often require resuscitation, surgery, bleeding control, and infection treatment, often resulting in diagnosis by a diverse range of healthcare providers. MCIRCC is developing new technologies for the treatment challenges a patient faces as they move from one point of care to the next. 

On the battlefield, approximately 80% of all deaths occur within the first 30 minutes of wounding. Despite major advances in modern civilian medicine, few have been made that have specific impact in combat casualty care to improve long-term survival and recovery of the severely wounded soldier. The complexity and severity of wounds incurred on the battlefield are beyond what we experience at home, however, several important medical and surgical innovations created for military conflicts have found their way into everyday emergency and critical care practice. Research done at MCIRCC plays a significant role in developing a new generation of adaptive tools and devices that can be used to save lives both on the battlefield and here at home.


Licensed and Emerging Products

Research Grants

Combat Casualty Care Headlines: